Intuitive Surgical price target raised to $622 from $561 at BTIG
BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $622 from $561 and keeps a Buy rating on the shares after its Q4 earnings ...
BTIG Reaffirms Their Hold Rating on United Therapeutics (UTHR)
BTIG analyst Julian Harrison maintained a Hold rating on United Therapeutics (UTHR – Research Report) on January 21. The company’s shares ...
bovnews3h
Why Did BTIG Research Give Plug Power Inc (PLUG) Stock Neutral Rating?
Plug Power Inc (PLUG) stock saw a modest uptick, ending the day at $2.09 which represents a slight increase of $0.06 or 2.96% from the prior close of $2.03. The stock opened at $2.03 and touched a low ...
BTIG cuts Outset Medical target to $3, maintains Buy rating
BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease ...
BTIG reiterates Buy on Ideaya stock, cites significant updates
Tuesday, shares of Ideaya Biosciences (NASDAQ:IDYA), trading at $22.18 near its 52-week low of $22.10, drew attention as BTIG analysts maintained their Buy rating and $62.00 price target. According to ...
bovnews5h
Wolfe Research Issues Outperform Rating for FTAI Aviation Ltd (FTAI) Stock
FTAI Aviation Ltd (FTAI) stock saw a modest uptick, ending the day at $101.5 which represents a slight increase of $9.51 or 10.34% from the prior close of $91.99. The stock opened at $91.93 and ...
BTIG to Donate $1 Million to Los Angeles Wildfire Recovery Efforts
BTIG announced today that it will commit to donating $1 million dollars to wildfire relief and restoration efforts in Los Angeles, California. The funds will be donated to reputable organizations ...
Nasdaq20d
BTIG sees Uber Q4 bookings more in middle than high-end of outlook
BTIG analyst Jake Fuller says that while Uber‘s (UBER) commentary on its U.S. rideshare business “felt constructive” at intra-quarter appearances, the firm’s receipt data was “more ...
Nasdaq1mon
BTIG Initiates Coverage of Avalo Therapeutics (AVTX) with Buy Recommendation
As of December 3, 2024, the average one-year price target for Avalo Therapeutics is $35.70/share. The forecasts range from a low of $35.35 to a high of $36.75. The average price target represents ...
Instacart holds leading edge in grocery delivery category - analysts
Instacart (CART) receives positive analyst coverage as a leader in the grocery delivery category with strong growth prospects ...
Yahoo Finance1mon
Avalo Therapeutics initiated with a Buy at BTIG
https://www.tipranks.com/news/the-fly/springworks-therapeutics-price-target-lowered-to-55-from-58-at-bofa BTIG analyst Julian Harrison initiated coverage of Avalo ...
Morningstar7d
BTIG to Donate $1 Million to Los Angeles Wildfire Recovery Efforts
BTIG announced today that it will commit to donating $1 million dollars to wildfire relief and restoration efforts in Los Angeles, California. The funds will be donated to reputable organizations ...